monoclonal antibody therapy

TWiV 578: Prometheus project

Vincent speaks with members of Prometheus, a team of academic and industrial scientists assembled to develop antibody-based therapeutics against infections caused by tick-borne Crimean-Congo hemorrhagic fever virus and rodent-borne hantaviruses, for which no approved vaccines or specific drugs are available. Click arrow to play Download TWiV 578 (55 MB .mp3, 91 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become …

TWiV 578: Prometheus project Read More »

Could the Ebola virus epidemic have been prevented?

The cover of this week’s issue of Businessweek declares that ‘Ebola is coming’ in letters colored like blood, with the subtitle ‘The US had a chance to stop the virus in its tracks. It missed’. Although the article presents a good analysis of the hurdles in developing antibody therapy for Ebola virus infection, the cover …

Could the Ebola virus epidemic have been prevented? Read More »

Ebolavirus vaccines and antivirals

As the epidemic of Zaire ebolavirus in Western Africa continues (1,779 cases and 961 deaths in four countries), many are questioning why there are no means of preventing or stopping infection. In the past two decades there has been substantial research into developing and testing active and passive vaccines and antiviral drugs, although none have yet been licensed for use …

Ebolavirus vaccines and antivirals Read More »

Scroll to Top